Found: 7
Select item for more details and to access through your institution.
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in ...
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 13, p. 1704, doi. 10.1177/1352458514532317
- By:
- Publication type:
- Article
Opportunities and challenges with decentralized trials in Neuroscience.
- Published in:
- Biometrical Journal, 2023, v. 65, n. 8, p. 1, doi. 10.1002/bimj.202200370
- By:
- Publication type:
- Article
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 12, p. 2627, doi. 10.1007/s00415-015-7834-0
- By:
- Publication type:
- Article
Sotrastaurin and Tacrolimus Coadministration: Effects on Pharmacokinetics and Biomarker Responses.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 11, p. 1260, doi. 10.1177/0091270009360534
- By:
- Publication type:
- Article
Quantifying unrecognised replication present in reports of HIV diagnoses.
- Published in:
- Statistics in Medicine, 2014, v. 33, n. 16, p. 2774, doi. 10.1002/sim.6121
- By:
- Publication type:
- Article
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 11, p. 1134, doi. 10.1007/s12325-014-0167-z
- By:
- Publication type:
- Article